Four Perspectives on Business Model Evolution in Synthetic Biology

Authors

  • Karl Schmieder
  • Clara Andrew-Wani

DOI:

https://doi.org/10.5912/jcb668

Keywords:

synthetic biology, business model

Author Biographies

  • Karl Schmieder
    is the founder of MessagingLab, a strategic communications  firm focused on life sciences companies.
  • Clara Andrew-Wani
    is completing her Master of Business and Science degree in biotechnology and genomics at Rutgers University.

References

Friedman, Yali. “Time for a New Business Model?†Journal of Commercial Biotechnology (2010) 16, 1–2. doi:10.1057/jcb.2009.33

Bethencourt, Ryan. Biotech’s Cambrian Era. BioCoder, Fall 2013. Accessed at http://programming.oreilly.com/2013/10/biotechs-cambrian-era.html

Downloads

Published

2014-07-01

Issue

Vol. 20 No. 3 (2014)

Section

Conference Report